Biomarkers for immunotherapy for treatment of glioblastoma

Immunotherapy is a promising new therapeutic field that has demonstrated significant benefits in many solid-tumor malignancies, such as metastatic melanoma and non-small cell lung cancer. However, only a subset of these patients responds to treatment. Glioblastoma (GBM) is the most common malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynes, John P, Nwankwo, Anthony K, Sur, Hannah P, Sanchez, Victoria E, Sarpong, Kwadwo A, Ariyo, Oluwatobi I, Dominah, Gifty A, Nduom, Edjah K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264836/
https://www.ncbi.nlm.nih.gov/pubmed/32474411
http://dx.doi.org/10.1136/jitc-2019-000348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264836/
https://www.ncbi.nlm.nih.gov/pubmed/32474411
http://dx.doi.org/10.1136/jitc-2019-000348

Ejemplares similares